Endothelin-1(1-31) induces spreading depolarization in rats

Acta Neurochirurgica, Supplementum

Volumn 110, Issue , 2011, Pages 111-117

  Jorks, D ^a   Major, S ^a   Oliveira Ferreira, A I ^a   Kleeberg, J ^b   Dreier, J P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Electrocorticography; Endothelin 1; Ischemia; Spreading depression; Stroke; Vasospasm

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN 1 [1-31]; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; CARBON DIOXIDE TENSION; CONFERENCE PAPER; CONTROLLED STUDY; DEPOLARIZATION; DIRECT CURRENT; DURA MATER; ELECTROCORTICOGRAPHY; MALE; MEAN ARTERIAL PRESSURE; METABOLISM; NONHUMAN; RAT; SOMATOSENSORY CORTEX; SPREADING CORTICAL DEPRESSION; SPREADING DEPOLARIZATION;

EID: 85052609418     PISSN: 00651419     EISSN: 00016268     Source Type: Book Series    
DOI: 10.1007/978-3-7091-0353-1_20     Document Type: Conference Paper

References (48)

1. Kistler JP, Crowell RM, Davis KR, Heros R, Ojemann RG, Zervas T, et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: A prospective study. Neurology 1983;33:424-36.
2. Pluta RM, Afshar JK, Boock RJ, Oldfield EH. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage. J Neurosurg. 1998;88:557-61.
3. Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: The emerging revolution. Nat Clin Pract Neurol. 2007;3:256-63.
4. Schuknecht B, Fandino J, Yuksel C, Yonekawa Y, Valavanis A. Endovascular treatment of cerebral vasospasm: Assessment of treatment effect by cerebral angiography and transcranial colour Doppler sonography. Neuroradiology 1999;41:453-62.
5. Ohkuma H, Manabe H, Tanaka M, Suzuki S. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2000;31:1621-27.
6. Dreier JP, Korner K, Ebert N, Gorner A, Rubin I, Back T, et al. Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab. 1998;18:978-90.
7. Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J, et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 2009;132:1866-81.
8. Zimmermann MMD, Seifert VMDP. Endothelin and subarachnoid hemorrhage: An overview. Neurosurgery 1998;43:863-75.
9. Macrae IM, Robinson MJ, Graham DI, Reid JL, McCulloch J. Endothelin-1-induced reductions in cerebral blood-flow - dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab. 1993;13:276-84.
10. Fuxe K, Bjelke B, Andbjer B, Grahn H, Rimondini R, Agnati LF. Endothelin-1 induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical ischemia. Neuroreport 1997;8:2623-29.
11. Dreier JP, Kleeberg J, Alam M, Major S, Kohl-Bareis M, Petzold GC, et al. Endothelin-1-induced spreading depression in rats is associated with a microarea of selective neuronal necrosis. Exp Biol Med (Maywood). 2007;232:204-13.
12. Chow M, Dumont AS, Kassell NF. Endothelin receptor antagonists and cerebral vasospasm: An update. Neurosurgery 2002;51:1333-41; discussion 1342.
13. Vatter H, Konczalla J, Weidauer S, Preibisch C, Zimmermann M, Raabe A, et al. Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function. J Neurosurg. 2007;107:121-27.
14. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): Randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008;39:3015-21.
15. Dreier JP, Petzold G, Tille K, Lindauer U, Arnold G, Heinemann U, et al. Ischaemia triggered by spreading neuronal activation is inhibited by vasodilators in rats. J Physiol. 2001;531:515-26.
16. Petzold GC, Einhaupl KM, Dirnagl U, Dreier JP. Ischemia triggered by spreading neuronal activation is induced by endothelin-1 and hemoglobin in the subarachnoid space. Ann Neurol. 2003;54: 591-98.
17. Cosenzi A. Enrasentan, an antagonist of endothelin receptors. Cardiovasc Drug Rev. 2003;21:1-16.
18. D'Orleans-Juste P, Plante M, Honore JC, Carrier E, Labonte J. Synthesis and degradation of endothelin-1. Can J Physiol Pharmacol. 2003;81:503-10.
19. Nakano A, Kishi F, Minami K, Wakabayashi H, Nakaya Y, Kido H. Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells. J Immunol. 1997;159:1987-92.
20. Fecteau MH, Honore JC, Plante M, Labonte J, Rae GA, D'Orleans-Juste P. Endothelin-1 (1-31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo. Hypertension 2005;46:87-92.
21. Baltatu O, Nishimura H, Hoffmann S, Stoltenburg G, Haulica ID, Lippoldt A, et al. High levels of human chymase expression in the pineal and pituitary glands. Brain Res. 1997;752:269-78.
22. Dreier JP, Kleeberg J, Petzold G, Priller J, Windmuller O, Orzechowski HD, et al. Endothelin-1 potently induces Leao's cortical spreading depression in vivo in the rat: A model for an endothelial trigger of migrainous aurá Brain 2002;125:102-12.
23. Kleeberg J, Petzold GC, Major S, Dirnagl U, Dreier JP. ET-1 induces cortical spreading depression via activation of the ETA receptor/phospholipase C pathway in vivo. Am J Physiol Heart Circ Physiol. 2004;286:H1339-46.
24. Leslie SJ, Rahman MQ, Denvir MA, Newby DE, Webb DJ. Endothelins and their inhibition in the human skin microcirculation: ET[1-31], a new vasoconstrictor peptide. Br J Clin Pharmacol. 2004;57:720-25.
25. Maguire JJ, Kuc RE, Davenport AP. Vasoconstrictor activity of novel endothelin peptide, ET-1(1-31), in human mammary and coronary arteries in vitro. Br J Pharmacol. 2001;134:1360-66.
26. Somjen GG. Ions in the brain. Normal function, seizures and stroke. New York: Oxford University Press; 2004.
27. Dreier JP, Woitzik J, Fabricius M, Bhatia R, Major S, Drenckhahn C, et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 2006;129:3224-37.
28. Dohmen C, Sakowitz OW, Fabricius M, Bosche B, Reithmeier T, Ernestus RI, et al. Spreading depolarizations occur in human ischemic stroke with high incidence. Ann Neurol. 2008;63:720-28.
29. Mies G, Paschen W. Regional changes of blood flow, glucose, and ATP content determined on brain sections during a single passage of spreading depression in rat brain cortex. Exp Neurol. 1984;84: 249-58.
30. Busch E, Gyngell ML, Eis M, Hoehn-Berlage M, Hossmann KA. Potassium-induced cortical spreading depressions during focal cerebral ischemia in rats: Contribution to lesion growth assessed by diffusion-weighted NMR and biochemical imaging. J Cereb Blood Flow Metab. 1996;16:1090-99.
31. Koroleva VI, Bures J. Circulation of cortical spreading depression around electrically stimulated areas and epileptic foci in the neocortex of rats. Brain Res. 1979;173:209-15.
32. Nedergaard M, Hansen AJ. Characterization of cortical depolarizations evoked in focal cerebral ischemia. J Cereb Blood Flow Metab. 1993;13:568-74.
33. Takano K, Latour LL, Formato JE, Carano RA, Helmer KG, Hasegawa Y, et al. The role of spreading depression in focal ischemia evaluated by diffusion mapping. Ann Neurol. 1996;39: 308-18.
34. Kasuya H, Weir BK, White DM, Stefansson K. Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells. J Neurosurg. 1993;79:892-98.
35. Ohlstein EH, Storer BL. Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg. 1992;77:274-78.
36. Schini VB, Hendrickson H, Heublein DM, Burnett JC, Jr., Vanhoutte PM. Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur J Pharmacol. 1989;165:333-34.
37. Xie A, Aihara Y, Bouryi VA, Nikitina E, Jahromi BS, Zhang ZD, et al. Novel mechanism of endothelin-1-induced vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2007;27: 1692-701.
38. Kastner S, Oertel MF, Scharbrodt W, Krause M, Boker DK, Deinsberger W. Endothelin-1 in plasma, cisternal CSF and microdialysate following aneurysmal SAH. Acta Neurochir (Wien). 2005;147:1271-79; discussion 1279.
39. Pluta RM, Boock RJ, Afshar JK, Clouse K, Bacic M, Ehrenreich H, et al. Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg. 1997;87: 287-93.
40. Mascia L, Fedorko L, Stewart DJ, Mohamed F, terBrugge K, Ranieri VM, et al. Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Stroke 2001;32:1185-90.
41. Yoshizumi M, Inui D, Okishima N, Houchi H, Tsuchiya K, Wakabayashi H, et al. Endothelin-1-(1-31), a novel vasoactive peptide, increases [Ca2+]i in human coronary artery smooth muscle cells. Eur J Pharmacol. 1998;348:305-9.
42. Yoshizumi M, Kim S, Kagami S, Hamaguchi A, Tsuchiya K, Houchi H, et al. Effect of endothelin-1 (1-31) on extracellular signal-regulated kinase and proliferation of human coronary artery smooth muscle cells. Br J Pharmacol. 1998;125:1019-27.
43. Rossi GP, Andreis PG, Colonna S, Albertin G, Aragona F, Belloni AS, et al. Endothelin-1[1-31]: A novel autocrine-paracrine regulator of human adrenal cortex secretion and growth. J Clin Endocrinol Metab. 2002;87:322-28.
44. Hayasaki-Kajiwara Y, Naya N, Shimamura T, Iwasaki T, Nakajima M. Endothelin generating pathway through endothelin1-31 in human cultured bronchial smooth muscle cells. Br J Pharmacol. 1999;127:1415-21.
45. Lu Y, Wang LG, Liao Z, Tang CS, Wang WZ, Yuan WJ. Cardiovascular effects of centrally applied endothelin-1 1-31 and its relationship to endothelin-1 1-21 in rats. Auton Neurosci. 2007;133:146-52.
46. Wada A, Tsutamoto T, Ohnishi M, Sawaki M, Fukai D, Maeda Y, et al. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: Comparison of effects with those of endothelin A receptor antagonism. Circulation 1999;99:570-77.
47. Strbian D, Kovanen PT, Karjalainen-Lindsberg ML, Tatlisumak T, Lindsberg PJ. An emerging role of mast cells in cerebral ischemia and hemorrhage. Ann Med. 2009;1:1-133
48. Cui P, Tani K, Kitamura H, Okumura Y, Yano M, Inui D, et al. A novel bioactive 31-amino acid endothelin-1 is a potent chemotactic peptide for human neutrophils and monocytes. J Leukoc Biol. 2001;70:306-12.